Qisda Corporation · TWSE:2352

Qisda — Q4 2020 Earnings Presentation

20 slides from Qisda's earnings presentation, Mar 25, 2021

  1. Slide 1: Qisda Corporation Investor Conference: 2020 Q4 Results

    Qisda Corporation Investor Conference: 2020 Q4 Results March 25, 2021

  2. Slide 2: Participants

    Participants Chairman Peter Chen CFO Jasmin Hung GM, Information Technology Business Group Joe Huang Commercial and Industrial Business Group GM, Business Solutions Group Michael Lee GM, Medical Devices Business Group Harry Yang GM, Networking and Communication Business Group April Huang CIO Michael

  3. Slide 3: Agenda

    Agenda 1. 2020 Q4 Financial Results and Business Highlights CFO Jasmin Hung 2. Business Update and Outlook Chairman Peter Chen 3. Q&A 3

  4. Slide 4: Safe Harbor Notice

    Safe Harbor Notice We have made forward-looking statements in the presentation. Our forward-looking statements contain information regarding, among other things, our financial conditions, future expansion plans and business strategies. We have based these forward-looking statements on our current ex

  5. Slide 5: 1. 2020 Q4 Financial Results and Business Highlights

    1. 2020 Q4 Financial Results and Business Highlights CFO Jasmin 5

  6. Slide 6: Business Groups

    2020 Revenue: NTD 191.7 billion Business Groups 2352 Group employees: Over 33,000 Global presences: 29 countries 14 listed companies in Taiwan ICT MEDICAL BBS NCG OTHERS (60%) (6%) (11%) (17%) (6%) ➢ Displays ➢ Medical Services ➢ Smart Hospital ➢ LAN/MAN ➢ Material • Gaming • BenQ Medical Center in

  7. Slide 7: Q4 Highlights

    Q4 Highlights ✓ Revenue from High-value Added business account for 34% of Q4 revenue, and 28% of 2020 revenue. ✓ Highest Single-Quarter Revenue, YoY increased by 25%, EPS reached $0.90 (increased by $0.57). • Operating Income increased by 55%, Net income attributable to Qisda increased by 178%. ✓ Wh

  8. Slide 8: Consolidated Statement of Comprehensive Income (Quarterly)

    Consolidated Statement of Comprehensive Income (Quarterly) Amount : NT$ Million YoY QoQ 2020 Q4 2019 Q4 2020 Q3 amt g% amt g% Net Sales 57,134 100.0% 45,862 100.0% 11,272 25% 51,695 100.0% 5,440 11% Cost of Goods Sold (48,984) (39,990) (8,994) (44,211) (4,773) Gross Margin 8,150 14.3% 5,872 12.8% 2,

  9. Slide 9: Consolidated Statement of Comprehensive Income (Second half)

    Consolidated Statement of Comprehensive Income (Second half) Amount : NT$ Million YoY 20' 2H vs 1H 2020 2H 2019 2H 2020 1H amt g% amt g% Net Sales 108,829 100.0% 88,666 100.0% 20,163 23% 82,873 100.0% 25,956 31% Cost of Goods Sold (93,195) (76,727) (16,469) (71,680) (21,515) Gross Margin 15,634 14.4

  10. Slide 10: Consolidated Statement of Comprehensive Income (YTD)

    Consolidated Statement of Comprehensive Income (YTD) Amount : NT$ Million YTD YoY 2020 2019 amt g% Net Sales 191,702 100.0% 169,754 100.0% 21,948 13% Cost of Goods Sold (164,875) (146,704) (18,171) Gross Margin 26,827 14.0% 23,050 13.6% 3,777 16% Operating Expenses (20,214) -10.5% (16,822) -9.9% (3,

  11. Slide 11: Consolidated Balance Sheet Highlights

    Consolidated Balance Sheet Highlights Amount : NT$ Million QoQ YoY 2020.12.31 2020.09.30 2019.12.31 amt g% amt g% Cash & Equivalent 22,540 13% 17,903 11% 4,638 26% 10,781 8% 11,760 109% Accounts Receivable 36,502 21% 35,931 22% 571 2% 31,300 23% 5,202 17% Inventory 35,139 21% 32,711 20% 2,428 7% 27,

  12. Slide 12: Key Financial Ratios

    Key Financial Ratios 2020.12.31 2020.09.30 QoQ 2019.12.31 YoY (a) AR Turnover (Days) 79 85 -6 79 +0 Inventory Turnover (Days) 70 72 -2 66 +4 AP Turnover (Days) 79 79 +0 77 +2 Cash Conversion Cycle (Days) 70 78 -8 68 +2 ROE (annualized) (a) 11.9% 10.2% +1.7 ppt 10.0% +1.9 ppt Current ratio 124% 121%

  13. Slide 13: Revenue Breakdown by Business (Quarterly)

    Revenue Breakdown by Business (Quarterly) High-value added % 13% 14% 17% 20% 22% 22% 31% 34% 100% 6% 7% 10% NCG 14% 16% 15% 13% 17% 7% 7% BBS 7% 7% 8% 7% 7% Medical 80% 7% 6% 12% 6% 11% 8% 7% Others 6% 6% ICT 8% 6% 60% High value-add 40% 80% 78% 76% 74% 70% 71% 61% 60% 20% 0% Q1'19 Q2'19 Q3'19 Q4'19

  14. Slide 14: Revenue of High-value Added Business

    Revenue of High-value Added Business • Q3 2020 reached 31%, Q4 increased to 34%, whole year accounted for 28%. • Qisda is moving toward to the goal to have high-value added business to account for more than half of total revenue. 34% 31% NCG 30% 30% 28% 17% BBS 13% 9% Medical 20% 20% 16% High-value

  15. Slide 15: 2. Business Update and Outlook

    2. Business Update and Outlook Chairman Peter 15

  16. Slide 16: Qisda's Vision

    Qisda’s Vision High-value added business will account for more than half of the revenue by 2022 16

  17. Slide 17: Qisda's Winning Strategy

    Qisda’s Winning Strategy Current Business Optimization Fast Expansion for Medical Businesses ICT Products ( No. 2 in Monitor, Medical Service, Equipment & Consumables No.1 in DLP Projector, Others ) Major Pillars 5G Network Business Acceleration on Strategic Placement Solution Development Comprehens

  18. Slide 18: Q1 2021 Outlook

    Q1 2021 Outlook ✓ Business Driver • Comparing with Q1 2020, revenue of Q1 2021 is expected to grow positively (YTD Feb 2021 revenue increased 30% comparing with same period in 2020). • Comparing with Q1 2020, BenQ Medical Center’s revenue in Q1 2021 is expected to have high growth rate, while other

  19. Slide 19: 3. Q&A

    3. Q&A 19

  20. Slide 20: Qisda Value-Up Solutions

    Oisda Value-Up Solutions Qisda

Qisda — Q4 2020 Earnings Presentation on 6ix